Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab.

Literature DB >> 22398084

Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab.

Kum C Fok¹, Watson W S Ng, Christopher J A Henderson, Susan J Connor.

Abstract

The advance of anti-tumour necrosis factor (TNF) therapy had dramatically changed the treatment algorithm of inflammatory bowel disease (IBD). This had significantly improved the quality of life for patients with Crohn's disease (CD) and ulcerative colitis (UC).(1) However, side-effects of anti-TNF treatment were unavoidable with paradoxical inflammation (for example leucocytoclastic vasculitis and psoriasis) being well-known phenomena of anti-TNF therapy.(2) We report a case of infliximab induced cutaneous sarcoidosis in a patient with ulcerative colitis and review the literature. Crown

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2012 PMID： 22398084 DOI： 10.1016/j.crohns.2012.01.008

Source DB: PubMed Journal: J Crohns Colitis ISSN： 1873-9946 Impact factor: 9.071

Keyword Cloud
Cited

11 in total

Review 1. Paradoxical inflammation induced by anti-TNF agents in patients with IBD.

Authors: Isabelle Cleynen; Séverine Vermeire
Journal: Nat Rev Gastroenterol Hepatol Date: 2012-07-03 Impact factor: 46.802

Review 2. The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.

Authors: Julie H Wu; Sotonye Imadojemu; Avrom S Caplan
Journal: Am J Clin Dermatol Date: 2022-05-18 Impact factor: 6.233

3. Plant flavonol isorhamnetin attenuates chemically induced inflammatory bowel disease via a PXR-dependent pathway.

Authors: Wei Dou; Jingjing Zhang; Hao Li; Sandhya Kortagere; Katherine Sun; Lili Ding; Gaiyan Ren; Zhengtao Wang; Sridhar Mani
Journal: J Nutr Biochem Date: 2014-05-09 Impact factor: 6.048

4. Isolated Gastrointestinal Sarcoidosis Involving Multiple Gastrointestinal Sites Presenting as Chronic Diarrhea.

Authors: Lauren Stemboroski; Bilkisu Gaye; Raafat Makary; Carmela Monteiro; Emely Eid
Journal: ACG Case Rep J Date: 2016-12-21

5. Certolizumab Pegol-Induced Folliculitis-Like Lichenoid Sarcoidosis in a Patient with Rheumatoid Arthritis.

Authors: Hiroyuki Sakai; Wakana Nomura; Motoshi Sugawara
Journal: Case Rep Dermatol Date: 2017-09-11

6. Systemic Sarcoidosis Associated with Certolizumab Pegol Treatment for Rheumatoid Arthritis: A Case Report and Review of the Literature.

Authors: Keigo Koda; Mikio Toyoshima; Tsuyoshi Nozue; Takafumi Suda
Journal: Intern Med Date: 2020-05-08 Impact factor: 1.271

Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab.

Review 1. Paradoxical inflammation induced by anti-TNF agents in patients with IBD.

Review 2. The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.

3. Plant flavonol isorhamnetin attenuates chemically induced inflammatory bowel disease via a PXR-dependent pathway.

4. Isolated Gastrointestinal Sarcoidosis Involving Multiple Gastrointestinal Sites Presenting as Chronic Diarrhea.

5. Certolizumab Pegol-Induced Folliculitis-Like Lichenoid Sarcoidosis in a Patient with Rheumatoid Arthritis.

6. Systemic Sarcoidosis Associated with Certolizumab Pegol Treatment for Rheumatoid Arthritis: A Case Report and Review of the Literature.

7. The antiprotozoal drug pentamidine ameliorates experimentally induced acute colitis in mice.

Review 8. Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?

9. Certolizumab-induced uveitis: a case report and review of the literature.

Review 10. Systemic sarcoidosis induced by etanercept: first Brazilian case report.